Cited by 185Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesAttention Deficit Hyperactivity Disorder

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Citalopram, Methylphenidate, or Their Combination in Geriatric Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

Open access

Lavretsky, Helen, Reinlieb, Michelle, St. Cyr, Natalie, Siddarth, Prabha, Ercoli, Linda M., Senturk, Damla·2015·American Journal of Psychiatry

DOI 10.1176/appi.ajp.2014.14070889PMC PMC4451432

Open this paper in CoChat — free account

Abstract

OBJECTIVE: The authors evaluated the potential of methylphenidate to improve antidepressant response to citalopram, as assessed by clinical and cognitive outcomes, in elderly depressed patients. METHOD: The authors conducted a 16-week randomized double-blind placebo-controlled trial for geriatric depression in 143 older outpatients diagnosed with major depression comparing treatment response in three treatment groups: methylphenidate plus placebo (N=48), citalopram plus placebo (N=48), and citalopram plus methylphenidate (N=47). The primary outcome measure was change in depression severity. Remission was defined as a score of 6 or less on the Hamilton Depression Rating Scale. Secondary outcomes included measures of anxiety, apathy, quality of life, and cognition. RESULTS: Daily doses ranged from 20 mg to 60 mg for citalopram (mean=32 mg) and from 5 mg to 40 mg for methylphenidate (mean=16 mg). All groups showed significant improvement in depression severity and in cognitive performance. However, the improvement in depression severity and the Clinical Global Impressions improvement score was more prominent in the citalopram plus methylphenidate group compared with the other two groups. Additionally, the rate of improvement in the citalopram plus methylphenidate group was significantly higher than that in the citalopram plus placebo group in the first 4 weeks of the trial. The groups did not differ in cognitive improvement or number of side effects. CONCLUSIONS: Combined treatment with citalopram and methylphenidate demonstrated an enhanced clinical response profile in mood and well-being, as well as a higher rate of remission, compared with either drug alone. All treatments led to an improvement in cognitive functioning, although augmentation with methylphenidate did not offer additional benefits.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2014.14070889

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T. P., & Westlake, L. (1992) · BMJ · doi:10.1136/bmj.305.6846.160 · Cited by 4,660

Show all 47 references

Research works printed but not linked: 3

Satel SL, 1989, J Clin Psychiatry, 50, 241
Lezak MD, 2004, Neuropsychological Assessment
Woods SW, 1986, J Clin Psychiatry, 47, 12

Sorted by citations

Cognitive function following a major depressive episode: a systematic review and meta-analysis
Semkovska, M., Quinlivan, L., O'Grady, T., Johnson, R., Collins, A., O'Connor, J., Knittle, H., Ahern, E., & Gload, T. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30291-3 · Cited by 631
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Psychobiological factors of resilience and depression in late life
Laird, K. T., Krause, B., Funes, C., & Lavretsky, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0424-7 · Cited by 229
Self-citation
Biological factors influencing depression in later life: role of aging processes and treatment implications
Szymkowicz, S. M., Gerlach, A., Homiack, D., & Taylor, W. D. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02464-9 · Cited by 234
Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study
Chang, Z., D’Onofrio, B. M., Quinn, P. D., Lichtenstein, P., & Larsson, H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.018 · Cited by 154
The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging
Brown, P. J., Rutherford, B. R., Yaffe, K. S., Tandler, J. M., Ray, J. L., Pott, E., Chung, S., & Roose, S. P. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.06.005 · Cited by 141
The neurobiology of apathy in depression and neurocognitive impairment in older adults: a review of epidemiological, clinical, neuropsychological and biological research
Steffens, D. C., Fahed, M., Manning, K. J., & Wang, L. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02292-3 · Cited by 128
Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis
Tunvirachaisakul, C., Gould, R. L., Coulson, M., Ward, E. V., Reynolds, G., Gathercole, R. L., Grocott, H., Supasitthumrong, T., Tunvirachaisakul, A., Kimona, K., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.008 · Cited by 118
Functional connectomics in depression: insights into therapies
Chai, Y., Sheline, Y. I., Oathes, D. J., Balderston, N. L., Rao, H., & Yu, M. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2023.05.006 · Cited by 112
Clinical correlates of resilience factors in geriatric depression
Laird, K. T., Lavretsky, H., Paholpak, P., Vlasova, R. M., Roman, M., St. Cyr, N., & Siddarth, P. (2019) · International Psychogeriatrics · doi:10.1017/s1041610217002873 · Cited by 93
Self-citation
Influences of dopaminergic system dysfunction on late-life depression
Taylor, W. D., Zald, D. H., Felger, J. C., Christman, S., Claassen, D. O., Horga, G., Miller, J. M., Gifford, K., Rogers, B., Szymkowicz, S. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01265-0 · Cited by 89
Treating to target in major depressive disorder: response to remission to functional recovery
McIntyre, R. S., Lee, Y. L., & Mansur, R. B. (2015) · CNS Spectrums · doi:10.1017/s1092852915000826 · Cited by 85
The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis
McIntyre, R. S., Lee, Y., Zhou, A. J., Rosenblat, J. D., Peters, E. M., Lam, R. W., Kennedy, S. H., Rong, C., & Jerrell, J. M. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000723 · Cited by 75
Pathomechanisms of Vascular Depression in Older Adults
Jellinger, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010308 · Cited by 82
Cognitive dysfunction in major depression: From assessment to novel therapies
Atique-Ur-Rehman, H., & Neill, J. C. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.013 · Cited by 72
Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives
Salagre, E., Solé, B., Tomioka, Y., Fernandes, B. S., Hidalgo-Mazzei, D., Garriga, M., Jimenez, E., Sanchez-Moreno, J., Vieta, E., & Grande, I. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.034 · Cited by 71
Treatment-Resistant Depression in Older Adults
Steffens, D. C. (2024) · New England Journal of Medicine · doi:10.1056/nejmcp2305428 · Cited by 80
Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review
Ngcobo, N. N. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01466-0 · Cited by 116
Biological Aging and the Future of Geriatric Psychiatry
Rutherford, B. R., Taylor, W. D., Brown, P. J., Sneed, J. R., & Roose, S. P. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw241 · Cited by 75
ADHD in old age: a review of the literature and proposal for assessment and treatment
Kooij, J. J. S., Michielsen, M., Kruithof, H. C., & Bijlenga, D. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1204914 · Cited by 69
Nicotine and networks: Potential for enhancement of mood and cognition in late-life depression
Gandelman, J. A., NEWHOUSE, P. A., & Taylor, W. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.018 · Cited by 61
Comparative Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation vs Citalopram for Major Depressive Disorder: A Randomized Trial
Li, S., Rong, P., Wang, Y., Jin, G., Hou, X., Li, S., Xiao, X., Zhou, W., Wu, Y., Liu, Y., et al. (2022) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2021.10.021 · Cited by 60
Drugs, games, and devices for enhancing cognition: implications for work and society
Brühl, A. B., & Sahakian, B. J. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13040 · Cited by 58
Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis
Ainsworth, N. J., Marawi, T., Maslej, M. M., Blumberger, D. M., McAndrews, M. P., Perivolaris, A., Pollock, B. G., Rajji, T. K., & Mulsant, B. H. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230392 · Cited by 57
Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000–2020: A systematic review and meta-analysis
Lin, Y.-H., Sahker, E., Shinohara, K., Horinouchi, N., Ito, M., Lelliott, M., Cipriani, A., Tomlinson, A., Baethge, C., & Furukawa, T. A. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101505 · Cited by 51
Association of Cerebral Small Vessel Disease With Gait and Balance Disorders
Su, C., Yang, X., Wei, S., & Zhao, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.834496 · Cited by 52
Attention-deficit hyperactivity disorder comorbidity and antidepressant resistance among patients with major depression: A nationwide longitudinal study
Chen, M., Pan, T., Hsu, J.-W., Huang, K., Su, T., Li, C., Lin, W.-C., Tsai, S., Chang, W.-H., Chen, T., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.09.369 · Cited by 50
Assessment of stimulant use and cardiovascular event risks among older adults
Tadrous, M., Shakeri, A., Chu, C., Watt, J., Mamdani, M. M., Juurlink, D. N., & Gomes, T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.30795 · Cited by 49
Depression in the medically ill
Rosenblat, J. D., Kurdyak, P. A., Cosci, F., Berk, M., Maes, M. H. J., Brunoni, A. R., Li, M., Rodin, G., McIntyre, R. S., & Carvalho, A. F. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419888576 · Cited by 47
Brain-based mechanisms of late-life depression: Implications for novel interventions
Gunning, F. M., Oberlin, L. E., Schier, M. M., & Victoria, L. W. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.002 · Cited by 49
Stimulants for depression: On the up and up?
Malhi, G. S., Byrow, Y., Bassett, D., Boyce, P., Hopwood, M., Lyndon, W., Mulder, R., Porter, R., Singh, A., & Murray, G. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416634208 · Cited by 46
The Frail Depressed Patient: A Narrative Review on Treatment Challenges
Aprahamian, I., Borges, M. K., Hanssen, D. J. C., Jeuring, H. W., & Voshaar, R. C. O. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s328432 · Cited by 45
Apathy Mediates Cognitive Difficulties in Geriatric Depression
Funes, C. M., Lavretsky, H., Ercoli, L. M., Cyr, N. S., & Siddarth, P. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.06.012 · Cited by 49
Self-citation
Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
Ficek, J., Zygmunt, M., Piechota, M., Hoinkis, D., Rodriguez Parkitna, J., Przewlocki, R., & Korostynski, M. (2016) · BMC Genomics · doi:10.1186/s12864-016-2713-3 · Cited by 42
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial
Maier, F., Spottke, A., Bach, J.-P., Bartels, C., Buerger, K., Dodel, R., Fellgiebel, A., Fliessbach, K., Frölich, L., Hausner, L., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.6027 · Cited by 46
Is treatment-resistant depression a useful concept?
Malhi, G. S., & Byrow, Y. (2016) · Evidence-Based Mental Health · doi:10.1136/eb-2015-102299 · Cited by 41
Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis
Szmulewicz, A. G., Angriman, F., Samamé, C., Ferraris, A., Vigo, D., & Strejilevich, S. A. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12712 · Cited by 37
Cognitive effects of vortioxetine in older adults: a systematic review
Bishop, M. M., Fixen, D. R., Linnebur, S. A., & Pearson, S. M. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211026796 · Cited by 39
Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic
Zhao, Y., Wu, X., Tang, M., Shi, L., Gong, S., Mei, X., Zhao, Z., He, J., Huang, L., & Cui, W. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1017203 · Cited by 49
Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study
Brumbaugh, S., Tuan, W., Scott, A. R., Latronica, J. R., & Bone, C. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101524 · Cited by 35
Advances in Pharmacotherapy of Late-Life Depression
Beyer, J. L., & Johnson, K. G. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0899-6 · Cited by 38
An assessor-blinded, randomized comparative trial of transcutaneous auricular vagus nerve stimulation (taVNS) combined with cranial electroacupuncture vs. citalopram for depression with chronic pain
Li, S., Zhang, Z., Jiao, Y., Jin, G., Wu, Y., Xu, F., Zhao, Y., Jia, H., Qin, Z., Zhang, Z., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.902450 · Cited by 35
Methylphenidate Attenuates the Cognitive and Mood Alterations Observed inMbnl2Knockout Mice and Reduces Microglia Overexpression
Ramon‐Duaso, C., Gener, T., Consegal, M., Fernández-Avilés, C., Gallego, J., Castarlenas, L., Swanson, M. S., de la Torre, R., Maldonado, R. J., Puig, M. V., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy164 · Cited by 32
Behavioral And Psychological Symptoms In Dementia
Cloak, N. L., & Khalili, Y. A. (2020) · StatPearls · Cited by 29
Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study
Zheng, H., Jia, F., Han, H., Wang, S., Guo, G., Quan, D., Li, G., & Huang, H. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.010 · Cited by 28
Amphetamine Use in the Elderly: A Systematic Review of the Literature
Sassi, K. L. M., Rocha, N. P., Colpo, G. D., John, V. P., & Teixeira, A. L. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191010093021 · Cited by 27
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Unipolar Nonpsychotic Depression
Giakoumatos, C. I., & Osser, D. N. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000197 · Cited by 27
Symptom management challenges in heart failure: pharmacotherapy considerations
Stewart, D., & McPherson, M. L. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9632-5 · Cited by 26
Resilience and White Matter Integrity in Geriatric Depression
Vlasova, R. M., Siddarth, P., Krause, B., Leaver, A. M., Laird, K. T., St Cyr, N., Narr, K. L., & Lavretsky, H. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.04.004 · Cited by 25
Self-citation
Resilience predicts remission in antidepressant treatment of geriatric depression
Laird, K. T., Lavretsky, H., St. Cyr, N., & Siddarth, P. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4953 · Cited by 23
Self-citation
Treatment resistant late-life depression: A narrative review of psychosocial risk factors, non-pharmacological interventions, and the role of clinical phenotyping
Patrick, R. E., Dickinson, R. A., Gentry, M. T., Kim, J. U., Oberlin, L. E., Park, S., Principe, J. L., Teixeira, A. L., & Weisenbach, S. L. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.017 · Cited by 27
Methylphenidate use in geriatric depression: A systematic review
Smith, K. R., Kahlon, C. H., Brown, J. N., & Britt, R. B. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5536 · Cited by 25
Pharmacotherapy of major depression in late life: what is the role of new agents?
Patel, K., Abdool, P. S., Rajji, T. K., & Mulsant, B. H. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1308484 · Cited by 26
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters
Tosh, D. K., Janowsky, A. J., Eshleman, A. J., Warnick, E., Gao, Z.-G., Chen, Z., Gizewski, E. T., Auchampach, J. A., Salvemini, D., & Jacobson, K. A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00141 · Cited by 23
The intraindividual impact of ADHD on the transition of adulthood to old age
Philipp-Wiegmann, F., Retz-Junginger, P., Retz, W., & Rösler, M. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0644-7 · Cited by 27
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2021) · Focus · doi:10.1176/appi.focus.19304 · Cited by 22
Response and Side Effects Using Stimulant Medication in Older Adults With ADHD: An Observational Archive Study
Michielsen, M., Kleef, D., Bijlenga, D., Zwennes, C. T. C., Dijkhuizen, K., Smulders, J., Hazewinkel, A. W. P., Beekman, A. T. F., & Kooij, J. J. S. (2020) · Journal of Attention Disorders · doi:10.1177/1087054720925884 · Cited by 21
Genomic predictors of remission to antidepressant treatment in geriatric depression using genome‐wide expression analyses: a pilot study
Eyre, H. A., Eskin, A., Nelson, S. F., Cyr, N. S., Siddarth, P., Baune, B. T., & Lavretsky, H. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4356 · Cited by 20
Self-citation
Why do stimulants not work in typical depression?
Hegerl, U., & Hensch, T. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416676369 · Cited by 19
Inference of causal relationships between sleep-related traits and 1,527 phenotypes using genetic data
García‐Marín, L. M., Campos, A. I., Martin, N. G., Cuéllar-Partida, G., & Rentería, M. E. (2020) · SLEEP · doi:10.1093/sleep/zsaa154 · Cited by 18
Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease
Akbar, U., & Friedman, J. H. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1077703 · Cited by 17
Contemporary methods of improving cognitive dysfunction in clinical depression
Knight, M. J., Mills, N. T., & Baune, B. T. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1610395 · Cited by 17
Are Amphetamines Associated with Adverse Cardiovascular Events Among Elderly Individuals?
Latronica, J. R., Clegg, T. J., Tuan, W., & Bone, C. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.06.210228 · Cited by 17
Testosterone Replacement Therapy in the Treatment of Depression
Anderson, D. J., Vazirnia, P., Loehr, C. A., Sternfels, W., Hasoon, J. J., Viswanath, O., Kaye, A. D., & Urits, I. (2022) · Health Psychology Research · doi:10.52965/001c.38956 · Cited by 18
A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition
Nelson, J. C., Gandelman, J. A., & Mackin, R. S. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.08.015 · Cited by 19
The use of stimulants in depression: Results from a self-controlled register study
Rohde, C., Brink, P., Østergaard, S. D., & Nielsen, J. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420924076 · Cited by 16
Intervention Research in Late-Life Depression: Challenges and Opportunities
Lavretsky, H. (2015) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.10.011 · Cited by 15
Self-citation
Predictors of Cognitive Improvement Following Treatment for Late-Life Depression
Siddarth, P., Funes, C. M., Laird, K. T., Ercoli, L., & Lavretsky, H. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720915515 · Cited by 15
Self-citation
Neurocognitive Correlates of Resilience in Late-Life Depression
Laird, K. T., Lavretsky, H., Wu, P., Krause, B., & Siddarth, P. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.08.009 · Cited by 14
Self-citation
A review of citalopram dose restrictions in the treatment of neuropsychiatric disorders in older adults
McCarrell, J. L., Bailey, T. A., Duncan, N. A., Covington, L. P., Clifford, K. M., Hall, R. G., & Blaszczyk, A. T. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.07.280 · Cited by 14
Therapy Strategies for Late-life Depression: A Review
Piel, C., & Quante, A. (2023) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000678 · Cited by 15
Bright light therapy accelerates the antidepressant effect of repetitive transcranial magnetic stimulation in treatment resistant depression: a pilot study
Barbini, B., Attanasio, F., Manfredi, E., Cavallini, M., Zanardi, R., & Colombo, C. (2021) · International journal of psychiatry in clinical practice · doi:10.1080/13651501.2021.1894579 · Cited by 12
Depression in the Medically Ill
Rodin, G., Craven, J., & Littlefield, C. H. (2017) · Routledge eBooks · doi:10.4324/9781315094991 · Cited by 14
The role of stimulants in late-life depression.
Nelson, J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030356 · Cited by 11
The effectiveness of off-label dopamine stimulating agents in depressive disorder: A systematic review and meta-analysis
Jeuring, H. W., d’Angremont, E., Tol, M. H., Risselada, A., Sommer, I. E., & Voshaar, R. C. O. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.115010 · Cited by 11
Analysis of Seasonal Clinical Characteristics in Patients With Bipolar or Unipolar Depression
Kong, S., Niu, Z., Lyu, D., Cui, L., Wu, X., Yang, L., Qiu, H. X., Gu, W., & Fang, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.847485 · Cited by 10
Apathy in Older Adults With and Without Dementia: An Integrative Review of Barriers and Facilitators to Care
Agboji, A., Freeman, S., Banner, D., Duchesne, A., Armstrong, J. J., & Martin‐Khan, M. (2024) · SAGE Open · doi:10.1177/21582440241241882 · Cited by 11
Hamilton scale and MADRS are interchangeable in meta-analyses but can disagree at trial level
Guizzaro, L., Morgan, D. D. V., Falco, A., & Gallo, C. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.04.022 · Cited by 10
The course of apathy in late‐life depression treated with electroconvulsive therapy; a prospective cohort study
Carlier, A., van Exel, E. R., Dols, A., Bouckaert, F., Sienaert, P. A., ten Kate, M., Wattjes, M. P., Vandenbulcke, M., Stek, M. L., & Rhebergen, D. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4917 · Cited by 11
Different Sides of Depression in the Elderly: An In-depth View on the Role of Aβ Peptides
Pagni, G., Tagliarini, C., Carbone, M. G., Imbimbo, B. P., Marazziti, D., & Pomara, N. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210921164816 · Cited by 10
Treatment resistant depression in elderly
Wang, S.-C., Yokoyama, J. S., Tzeng, N., Tsai, C.-F., & Liu, M. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.02.004 · Cited by 11
Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open‐labeled randomized control trial
Chen, H., Lin, Y., Zhao, Z., Lin, T., Lin, Q., Chen, X., Wu, W., Zeng, G., Wu, S., Liu, N., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14650 · Cited by 8
Guidelines for the assessment and management of residual sleepiness in obstructive apnea-hypopnea syndrome
Barateau, L., Baillieul, S., Andréjak, C., Béquignon, É., Boutouyrie, P., Dauvilliers, Y. A., Gagnadoux, F., Geoffroy, P. A., Micoulaud‐Franchi, J., Montani, D., et al. (2024) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2024.101105 · Cited by 10
Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity
Baweja, R. K., & Waxmonsky, J. G. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0135-3 · Cited by 10
Pharmacological Treatment of Major Depressive Disorder
Rosenblat, J. D., & McIntyre, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-58131-8.00008-2 · Cited by 9
Recommandations pour le bilan et la prise en charge de la somnolence résiduelle dans le syndrome d’apnées-hypopnées obstructives du sommeil
Barateau, L., Baillieul, S., Andréjak, C., Béquignon, É., Boutouyrie, P., Dauvilliers, Y. A., Gagnadoux, F., Geoffroy, P. A., Micoulaud‐Franchi, J., Montani, D., et al. (2023) · Médecine du Sommeil · doi:10.1016/j.msom.2023.06.001 · Cited by 7
Dichotomous effect of methylphenidate on microglia and astrocytes: Insights from in vitro and animal studies
Novo, J. P., Muga, M., Lourenço, T., Sanches, E. S., Leitão, R. A., & Silva, A. P. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.10.008 · Cited by 7
Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol
Atkins, C., Fordham, R. J., Clark, A., Stöckl, A., Jones, A., & Wilson, A. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018532 · Cited by 7
Treatment-Resistant Depression in the Elderly: Diagnostic and Treatment Approaches
Newman, B. M. (2016) · Current Geriatrics Reports · doi:10.1007/s13670-016-0186-5 · Cited by 9
Psychostimulant Augmentation of Antidepressant Therapy in Depression: a Systematic Review and Meta-Analysis
Janela, D., Jerónimo, J., Rema, J., Telles‐Correia, D., & Novais, F. (2023) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-023-00307-4 · Cited by 7
Cardiovascular Outcomes Among Older Individuals With Depression Prescribed Amphetamines: A Retrospective Cohort Study
Latronica, J. R., Tuan, W., Clegg, T. J., Silvis, M. L., & Bone, C. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac033 · Cited by 6
Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study
Krause, B., Siddarth, P., Milillo, M. M., Vlasova, R., Ercoli, L. M., Narr, K. L., & Lavretsky, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.548904 · Cited by 6
Self-citation
Cognitive factor structure and measurement invariance between healthy controls and patients with major depressive disorder
Yang, K., Hsieh, W.-C., & Chou, Y.-H. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.05.029 · Cited by 5
The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
Jang, S.-H., Bahk, W., Woo, Y. S., Seo, J. S., Park, Y., Kim, W. K., Jeong, J., Shim, S.-H., Lee, J. G., Jon, D., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031146 · Cited by 6
Pharmacotherapy for post-stroke aphasia: what are the options?
Berthier, M. L., & Dávila, G. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2221382 · Cited by 5
Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
Lanctôt, K. L., Rivet, L., Tumati, S., Perin, J., Sankhe, K., Vieira, D., Mintzer, J. E., Rosenberg, P. B., Shade, D. M., Lerner, A. J., et al. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.06.002 · Cited by 4
A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult
Blaszczyk, A. T., Mathys, M. L., & Le, J. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01051-3 · Cited by 9
Assessment and Treatment of ADHD in People Over 60
Kooij, J. J. S., Bijlenga, D., & Michielsen, M. (2019) · The ADHD Report · doi:10.1521/adhd.2019.27.4.1 · Cited by 6
Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
Clark, E. D., Perin, J., Herrmann, N., Brawman‐Mintzer, O., Lanctôt, K. L., Lerner, A. J., Mintzer, J. E., Padala, P. R., Rosenberg, P. B., Sami, S. A., et al. (2023) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12403 · Cited by 8
Late-Onset Depression in an Aging World: A Multidimensional Perspective on Risks, Mechanisms, and Treatment
D’Onofrio, A. M., Ferrajoli, G. F., Balzoni, L. M., Massetti, M., Zanzarri, A., Marano, G., Mazza, M., Koukopoulos, A. E., Kotzalidis, G. D., Moccia, L., et al. (2026) · Geriatrics · doi:10.3390/geriatrics11010013 · Cited by 4

Authors: Lavretsky, H., Reinlieb, M., St. Cyr, N., Siddarth, P., Ercoli, L. M., & Senturk, D.
Affiliations: University of California, Los Angeles (US)
From the UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles; the Department of Psychiatry, UCLA School of Medicine, Los Angeles; and the Departments of Biostatistics and Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles.
ORCID: Lavretsky, Helen
Siddarth, Prabha
Senturk, Damla
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 2015-06-01
Volume: 172
Issue: 6
Pages: 561-569
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/appi.ajp.2014.14070889
PMC: PMC4451432
OpenAlex: W2036375653
Cited by: 184
References: 47
Citations by year: 2026: 5 · 2025: 6 · 2024: 14 · 2023: 13 · 2022: 17 · 2021: 34 · 2020: 18 · 2019: 18 · 2018: 12 · 2017: 20 · 2016: 17 · 2015: 10
FWCI: 14.14
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institutes of Health
National Institute of Mental Health (MH086481, K24MH086481, R01MH077650, MH077650)
Jonsson Comprehensive Cancer Center
Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Keywords: geriatric depression, citalopram, methylphenidate, antidepressant augmentation, combination therapy, depression remission, cognitive function, anxiety, apathy, quality of life, antidepressant side effects
MeSH terms: Aged, Anxiety Disorders, Cognition Disorders, Major Depressive Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Methylphenidate, Middle Aged, Personality Assessment, Psychometrics, Quality of Life, Citalopram, Apathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Citalopram, Methylphenidate, or Their Combination in Geriatric Depression: A Randomized, Double-Blind, Placebo-Controlled Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks